Serum levels of vascular endothelial growth factor in chronic leukemias. A comparative study with emphasis on myeloproliferative disorders

Haematologica

Volumn 86, Issue 7, 2001, Pages 771-

  Molica, S ^a   Santoro, R ^a   Iuliano, F ^a   Di Raimondo, F ^a   Fichera, E ^a   Giustolisi, R ^a  

^a PUGLIESE CIACCIO HOSPITAL   (Italy)

Author keywords

Angiogenesis; Chronic leukemias; MMM; Myeloproliferative disorders; VEGF

Indexed keywords

VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; BONE MARROW; CHRONIC LYMPHATIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MYELOFIBROSIS; MYELOID METAPLASIA; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; THROMBOCYTE COUNT;

CASE-CONTROL STUDIES; CHRONIC DISEASE; ENDOTHELIAL GROWTH FACTORS; HUMANS; LEUKEMIA; LYMPHOKINES; MYELOPROLIFERATIVE DISORDERS; NEOVASCULARIZATION, PATHOLOGIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0034921196     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Angiogenesis in cancer, vascular, rheumatoid and other disease
2. Current status of antiangiogenic factors
3. Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes
4. Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: Significance for VEGF measurements and cancer biology
5. Elevated levels of angiogenic cytokines in the plasma of cancer patients
6. Evaluation and clinical correlations of bone marrow angiogenesis in myelofibrosis with myeloid metaplasia
7. Angiogenesis in acute myeloid leukemia